Inhalational Anthrax
📧 Sign up to get email alerts when something new happens for Inhalational Anthrax.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario [Phase 4]
Phase 4 trial update assessing the clinical benefit and safety of raxibacumab in patients with symptomatic inhalational anthrax in a mass ex…
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: Intramuscular Dose-Escalation Study With ETI-204 in Adult Volunteers [Phase 1]
Phase 1 intramuscular dose-escalation study of ETI-204 in adult volunteers has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: Safety, Tolerability and PK of Repeat Administration of Intravenous ETI-204 in Adult Volunteers [Phase 1]
Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of repeat IV administration of ETI-204 in healthy adult volunteers.
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of IV ETI-204 alone and with ciprofloxacin in healthy adult volunteers (…
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: Safety, Tolerability, and PK of a Single Intravenous Dose of ETI-204 in Adult Volunteers [Phase 1]
Phase 1 trial updates safety, tolerability, and pharmacokinetics of a single IV dose of ETI-204 in adults.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.